Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic? Leveraging data about a drug’s PK, PD and metabolic profiles; structural motifs; and physicochemical properties from preformulation and formulation studies can increase the chances of early phase success. Identifying issues early can result in fewer problems down the line and greater confidence in development decisions.
Download our whitepaper to learn more about strategies that help you make smarter decisions about your phase I strategy.